Trial intelligence / Profile preview

AUSTRI: Safety of Fluticasone/Salmeterol vs Fluticasone in Asthma

NCT01475721Phase 4Completed

Sponsor
GSK
Start
Nov 2011
Primary completion
Jun 2015
Modality
Small Molecules
Countries
33
01

Overview

A Phase 4 trial of salmeterol in asthma, sponsored by GSK. Started Nov 2011; status: completed.

02

Drugs

salmeterol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01475721.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01475721.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call